NOK:NYSENokia Corporation Sponsored Analysis
Data as of 2026-07-17 - not real-time
$10.38
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Nokia (NOK) trades at $10.38, well below its 20‑day ($12.71) and 50‑day ($13.79) moving averages, indicating a short‑term bearish bias, yet it remains above the 200‑day SMA ($8.92), suggesting a long‑term uptrend. The RSI of 32.5 points to oversold conditions, while a bearish MACD (‑0.73 vs ‑0.51 signal) and decreasing volume signal weakening momentum. Volatility is extreme at 76.9% over the past 30 days and beta is high (~1.6), amplifying price swings. Fundamentally, the stock appears overvalued: a trailing P/E of 64.9 dwarfs the industry average of 33.2, and the DCF‑derived fair value ($4.59) is less than half the market price. Revenue growth is modest (2.4% YoY) with thin operating (5.3%) and profit margins (4%), and a near‑100% payout ratio raises dividend sustainability concerns. Analysts remain optimistic, rating the stock as a “Buy” with a mean target of $15.16, implying ~46% upside, and recent headlines tout a partnership with Google Cloud Gemini and AI‑focused positioning, which could fuel a medium‑term rally. However, the combination of high valuation, thin margins, and elevated risk factors tempers enthusiasm.
Overall, NOK sits at a technical support of $10.25 and faces a resistance near $14.56. While the recent 127% YTD gain and “Extreme Greed” sentiment highlight strong market enthusiasm, the underlying fundamentals and valuation metrics suggest caution. Investors should weigh the upside potential against the high volatility, overvaluation, and dividend sustainability issues before committing.
Overall, NOK sits at a technical support of $10.25 and faces a resistance near $14.56. While the recent 127% YTD gain and “Extreme Greed” sentiment highlight strong market enthusiasm, the underlying fundamentals and valuation metrics suggest caution. Investors should weigh the upside potential against the high volatility, overvaluation, and dividend sustainability issues before committing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support ($10.25)
- Oversold RSI but bearish MACD
- High volatility and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus target $15.16 (~46% upside)
- Strategic AI/Google Cloud Gemini partnership
- Potential bounce from oversold conditions
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Fundamental overvaluation vs DCF fair value
- Thin margins and modest revenue growth
- Dividend payout ratio near 100% raising sustainability concerns
Key Metrics & Analysis
Financial Health
Revenue Growth2.40%
Profit Margin3.98%
P/E Ratio64.9
ROE3.72%
ROA2.76%
Debt/Equity15.63
P/B Ratio2.4
Op. Cash Flow$2.0B
Free Cash Flow$1.6B
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI32.5
Support$10.25
Resistance$14.56
MA 20$12.71
MA 50$13.79
MA 200$8.92
MACDBearish
VolumeDecreasing
Fear & Greed Index91.55
Valuation
Fair Value$4.59
Target Price$15.16
Upside/Downside46.01%
GradeOvervalued
TypeBlend
Dividend Yield1.46%
Risk Assessment
Beta1.57
Volatility76.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.